Sun BioPharma (NASDAQ:SNBP)’s stock price dropped 18.2% during mid-day trading on Tuesday . The company traded as low as $3.75 and last traded at $4.50, approximately 2,551 shares changed hands during trading. An increase of 183% from the average daily volume of 900 shares. The stock had previously closed at $5.50.
The firm’s 50 day simple moving average is $6.15.
About Sun BioPharma (NASDAQ:SNBP)
Sun BioPharma, Inc, a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase 1a/1b clinical trial for the treatment of patients with pancreatic cancer.
Further Reading: How to invest using market indexes
Receive News & Ratings for Sun BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sun BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.